You are here

Home

Clinical Trials: Musculoskeletal Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, January 17, 2022 - 12:00
Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis: a Randomized Controlled Trial, Baghdad 2022
Condition:   Treatment Complication
Intervention:   Procedure: autologous bone marrow aspirate concentrate by centrifugation
Sponsor:   zaid husein ali
Not yet recruiting
Posted: Friday, January 7, 2022 - 12:00
Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis
Condition:   Knee Osteoarthritis
Interventions:   Biological: SMUP-IA-01(low dose);   Biological: SMUP-IA-01(mid dose);   Drug: Active Control Group Sodium chloride
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Posted: Thursday, December 16, 2021 - 12:00
Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis
Condition:   Knee Osteoarthritis
Intervention:   Biological: Human umbilical cord mesenchymal stem cells
Sponsor:   Southwest Hospital, China
Not yet recruiting
Posted: Thursday, December 9, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis
Condition:   Osteoporosis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Tuesday, December 7, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA
Conditions:   Osteoarthritis;   Spinal Arthritis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Friday, November 19, 2021 - 12:00
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-3)
Conditions:   Muscular Dystrophies;   Muscular Dystrophy, Duchenne;   Muscular Disorders, Atrophic;   Muscular Diseases;   Neuromuscular Diseases;   Genetic Diseases, X-Linked;   Genetic Diseases, Inborn;   Nervous System Diseases
Interventions:   Biological: CAP-1002;   Drug: Placebo
Sponsor:   Capricor Inc.
Not yet recruiting
Posted: Thursday, October 21, 2021 - 12:00
Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.
Condition:   Knee Osteoarthritis
Interventions:   Drug: Autologous MSCs;   Drug: Allogenic MSCs;   Drug: Hyaluronic Acid
Sponsors:   Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León;   Instituto de Investigación Biomédica de Salamanca;   Spanish Clinical Research Network - SCReN;   Institut d'Investigacions Biomèdiques August Pi i Sunyer;   Hospital Universitari de Bellvitge
Recruiting
Posted: Monday, October 18, 2021 - 12:00
Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
Condition:   Osteoarthritis of Knee
Interventions:   Drug: MesoCellA-Ortho administration;   Drug: HA administration
Sponsors:   Jagiellonian University;   National Center for Research and Development, Poland;   KCRI
Not yet recruiting
Posted: Monday, October 4, 2021 - 12:00
Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD
Conditions:   Intervertebral Disc Degeneration;   Chronic Low-back Pain
Interventions:   Drug: Autologous BM-MSC;   Procedure: Sham
Sponsors:   Campus Bio-Medico University;   Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico;   Center for Outcomes Research and Clinical Epidemiology, Italy
Recruiting
Posted: Friday, October 1, 2021 - 12:00
MABs Therapy m.3243A>G Mutation Carriers
Condition:   Mitochondrial Myopathies
Intervention:   Biological: autologous mesoangioblasts
Sponsor:   Maastricht University
Recruiting

Pages